Literatura científica selecionada sobre o tema "Infections à Acinetobacter – Chimiothérapie"
Crie uma referência precisa em APA, MLA, Chicago, Harvard, e outros estilos
Índice
Consulte a lista de atuais artigos, livros, teses, anais de congressos e outras fontes científicas relevantes para o tema "Infections à Acinetobacter – Chimiothérapie".
Ao lado de cada fonte na lista de referências, há um botão "Adicionar à bibliografia". Clique e geraremos automaticamente a citação bibliográfica do trabalho escolhido no estilo de citação de que você precisa: APA, MLA, Harvard, Chicago, Vancouver, etc.
Você também pode baixar o texto completo da publicação científica em formato .pdf e ler o resumo do trabalho online se estiver presente nos metadados.
Artigos de revistas sobre o assunto "Infections à Acinetobacter – Chimiothérapie"
Wilson, Brigid M., Federico Perez, Qing Pan, Yunyun Jiang, Scott R. Evans e Robert A. Bonomo. "Acinetobacter Infections". Clinical Infectious Diseases 71, n.º 5 (17 de novembro de 2019): 1357–58. http://dx.doi.org/10.1093/cid/ciz1099.
Texto completo da fonteSnoeck, R., e E. De Clercq. "La chimiothérapie des infections a cytomégalovirus". Médecine et Maladies Infectieuses 18 (março de 1988): 79–84. http://dx.doi.org/10.1016/s0399-077x(88)80102-1.
Texto completo da fonteÖzgür, Özlem, e Necmi Aksaray. "Acinetobacter Infections and Treatment". Journal of Pediatric Infection 8, n.º 1 (17 de março de 2014): 28–32. http://dx.doi.org/10.5152/ced.2013.38.
Texto completo da fonteJoly-Guillou, M. L. "Acinetobacter et infections nosocomiales". Revue Française des Laboratoires 2002, n.º 345 (setembro de 2002): 14. http://dx.doi.org/10.1016/s0338-9898(02)80247-5.
Texto completo da fonteFalagas, M. E., E. A. Karveli, I. Kelesidis e T. Kelesidis. "Community-acquired Acinetobacter infections". European Journal of Clinical Microbiology & Infectious Diseases 26, n.º 12 (16 de agosto de 2007): 857–68. http://dx.doi.org/10.1007/s10096-007-0365-6.
Texto completo da fonteGarnacho-Montero, José, e Jean-François Timsit. "Managing Acinetobacter baumannii infections". Current Opinion in Infectious Diseases 32, n.º 1 (fevereiro de 2019): 69–76. http://dx.doi.org/10.1097/qco.0000000000000518.
Texto completo da fonteBergogne-Bérézin, E. "Treatment of Acinetobacter infections". Expert Opinion on Investigational Drugs 6, n.º 2 (fevereiro de 1997): 119–27. http://dx.doi.org/10.1517/13543784.6.2.119.
Texto completo da fonteMiah, Md Ruhul Amin. "Acinetobacter baumannii Hospital Acquired Infections." Bangladesh Journal of Medical Microbiology 13, n.º 1 (10 de janeiro de 2019): 1–3. http://dx.doi.org/10.3329/bjmm.v13i1.51778.
Texto completo da fonteFleming, Irma D., Monika A. Krezalek, Natalia Belogortseva, Alexander Zaborin, Jennifer Defazio, Laxmipradha Chandrasekar, Luis A. Actis, Olga Zaborina e John C. Alverdy. "Modeling Acinetobacter baumannii wound infections". Journal of Trauma and Acute Care Surgery 82, n.º 3 (março de 2017): 557–65. http://dx.doi.org/10.1097/ta.0000000000001338.
Texto completo da fonteLevin, Anna S. "Treatment of Acinetobacter spp. infections". Expert Opinion on Pharmacotherapy 4, n.º 8 (agosto de 2003): 1289–96. http://dx.doi.org/10.1517/14656566.4.8.1289.
Texto completo da fonteTeses / dissertações sobre o assunto "Infections à Acinetobacter – Chimiothérapie"
Antraygues, Kévin. "Conception, synthèse et évaluation biologique de nouveaux ansamacrolides dans le traitement d'infections bactériennes". Electronic Thesis or Diss., Université de Lille (2022-....), 2022. http://www.theses.fr/2022ULILS027.
Texto completo da fonteAntimicrobial resistance is a major public health issue nowadays and this will be even more true in the coming decades. Among the bacteria involved in this alarming phenomenon, Acinetobacter baumannii and Mycobacterium abscessus are both resistant to many antibiotics currently available on the market. Research and development of new antibiotics is therefore necessary to fight these pathogens.Rifabutin, a semi-synthetic macrocyle of the rifamycin class, has recently shown interesting in vitro activities against A. baumannii and M. abscessus, which then translated into in vivo efficacy. Rifabutin therefore seems to be promising to the fight against these bacteria, but the use of this antibiotic is currently limited. In order to treat an infection caused by A. baumannii, rifabutin requires to be injected by intravenous route, which is not so easy because of the low water solubility of the molecule. Concerning the treatment of M. abscessus infections, rifabutin, although effective in vivo, has moderate activity against this mycobacterium, which could lead to therapeutic escape.Therefore, the work presented in this thesis manuscript seeks to address the limitations of rifabutin mentioned above.In a first part, water-soluble prodrugs of rifabutin have been synthesized in order to allow an intravenous injection and thus fight effectively against A. baumannii infections. To achieve the release of rifabutin after enzymatic cleavage in plasma, an intramolecular cyclization strategy was employed. After evaluation of the compounds in plasma stability assays, structure-stability relationship studies were performed, leading to the identification of three promising prodrugs. Additional in vitro studies were then conducted such as the measurement of aqueous solubility and bacterial growth inhibition, and finally an in vivo pharmacokinetic study was performed to be able to select for a preclinical candidate.In a second part, analogues of rifabutin modified at the C25 position were synthesized to identify more potent compounds. Based on a parallel chemistry strategy, a large number of derivatives were rapidly obtained and then evaluated against M. abscessus in order to conduct structure-activity relationship studies
Henein, Alexandra Elisabeth. "The potential of bacteriophage therapy in Acinetobacter spp. infections". Thesis, University of Brighton, 2009. https://research.brighton.ac.uk/en/studentTheses/9726f331-e5dc-4b67-a282-44cac1fe978f.
Texto completo da fonteDiallo, Bruno Salla. "Études des acinetobacter : à propos de 98 souches isolées en milieu hospitalier". Bordeaux 2, 1990. http://www.theses.fr/1990BOR23091.
Texto completo da fonteGagné, Stéphanie. "Étude des mécanismes de virulence du pathogène nosocomial Acinetobacter baumannii". Thesis, Lyon, 2018. http://www.theses.fr/2018LYSE1045/document.
Texto completo da fonteA. baumannii is an hospital acquired pathogen which causes mainly ventilator associated infection, urinary tract infection and bacteraemia. Last years Multi Drug Resistant strains increase and nosocomial infection cause by A. baumannii also which led him as a serious health care problem. We compare different strains in propose to find phenotype that can explain hypervirulent strain emergence. We studied type six secretion and showed that the complexity of A. baumannii virulence mechanism. Indeed type six secretion system regulation is strain dependant. Secondary we study hypervirulent strain and showed that intracellular stage exists and there is intracellular replication. Also hypervirulent strain induces less immune response. Those two mechanisms can explain A. baumannii hypervirulent phenotype
Fabre, David. "Approche pharmacocinétique de l'antibiothérapie dans les infections pulmonaires". Montpellier 1, 1995. http://www.theses.fr/1995MON13504.
Texto completo da fonteHauret, Sylvie. "Epidémiologie moléculaire d'infections nosocomiales à Acinetobacter Baumannii dans un service de réanimation". Bordeaux 2, 1996. http://www.theses.fr/1996BOR2P039.
Texto completo da fonteWebster, Carol Ann. "The use of molecular typing systems for studying the epidemiology of Acinetobacter infections". Thesis, University of Nottingham, 1997. http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.388315.
Texto completo da fonteChou, So-ha, e 周素霞. "Molecular epidemiology of carbapenem-resistant acinetobacter baumanniiin patients and their surrounding environment". Thesis, The University of Hong Kong (Pokfulam, Hong Kong), 2012. http://hub.hku.hk/bib/B48333669.
Texto completo da fontepublished_or_final_version
Microbiology
Master
Master of Medical Sciences
Brandely, Marie-Laure. "Nouvelles prises en charge des principales infections fongiques hospitalières : évaluation pharmaco-économique". Paris 5, 1999. http://www.theses.fr/1999PA05P183.
Texto completo da fonteAdegoke, Anthony Ayodeji. "Commensal bacteria belonging to the Staphylococcus Acinetobacter and Stenotrophomonas genera as reservoirs of antibiotic resistance determinants in the environment of Nkonkobe Municipality, Eastern Cape Province , South Africa". Thesis, University of Fort Hare, 2012. http://hdl.handle.net/10353/6539.
Texto completo da fonteLivros sobre o assunto "Infections à Acinetobacter – Chimiothérapie"
E, Bergogne-Bérézin, Joly-Guillou M. L e Towner K. J, eds. Acinetobacter: Microbiology, epidemiology, infections, management. Boca Raton: CRC Press, 1996.
Encontre o texto completo da fonteE, Bergogne-Bérézin, Friedman Herman 1931-2007 e Bendinelli Mauro, eds. Acinetobacter biology and pathogenesis. New York: Springer, 2008.
Encontre o texto completo da fonteE, Bergogne-Bérézin, Friedman Herman 1931-2007 e Bendinelli Mauro, eds. Acinetobacter biology and pathogenesis. New York: Springer, 2008.
Encontre o texto completo da fonteUlrike, Gerischer, ed. Acinetobacter molecular biology. [Wymondham?]: Caister Academic Press, 2008.
Encontre o texto completo da fonteJacques, Thèze, e Debré Patrice, eds. Le sida à l'ère des multithérapies. Paris: Elsevier, 2000.
Encontre o texto completo da fonteDariosecq, Jean-Michel. Infection VIH: Mémento thérapeutique 2003. 6a ed. Rueil-Malmaison: Doin, 2003.
Encontre o texto completo da fonteTaylor, Yolanda. Battling HIV/AIDS: A decision maker's guide to the procurement of medicines and related supplies. Washington, DC: World Bank, 2004.
Encontre o texto completo da fonteP, Sawan Samuel, e Manivannan Gurusamy 1960-, eds. Antimicrobial/anti-infective materials: Principles, applications and devices. Lancaster, Pa: Technomic Pub. Co., 2000.
Encontre o texto completo da fonteFriedman, Herman, Mauro Bendinelli e Eugénie Bergogne-Bérézin. Acinetobacter: Biology and Pathogenesis. Springer, 2010.
Encontre o texto completo da fonteBergogne-Berezin, E., Marie-Laure Joly-Guillou e Kevin J. Towner. Acinetobacter: Microbiology, Epidemiology, Infections, Management. Taylor & Francis Group, 2020.
Encontre o texto completo da fonteCapítulos de livros sobre o assunto "Infections à Acinetobacter – Chimiothérapie"
Champion, Howard R., Nova L. Panebianco, Jan J. De Waele, Lewis J. Kaplan, Manu L. N. G. Malbrain, Annie L. Slaughter, Walter L. Biffl et al. "Acinetobacter Infections". In Encyclopedia of Intensive Care Medicine, 41–47. Berlin, Heidelberg: Springer Berlin Heidelberg, 2012. http://dx.doi.org/10.1007/978-3-642-00418-6_3.
Texto completo da fonteDijkshoorn, Lenie. "Acinetobacter baumannii". In Molecular Typing in Bacterial Infections, 433–56. Totowa, NJ: Humana Press, 2012. http://dx.doi.org/10.1007/978-1-62703-185-1_25.
Texto completo da fonteNurjadi, Dennis, e Sébastien Boutin. "Acinetobacter baumannii". In Molecular Typing in Bacterial Infections, Volume II, 113–29. Cham: Springer International Publishing, 2022. http://dx.doi.org/10.1007/978-3-030-83217-9_6.
Texto completo da fonteJoly-Guillou, M. L. "Nosocomial and Community-acquired Acinetobacter Infections". In Acinetobacter Biology and Pathogenesis, 155–65. New York, NY: Springer US, 2008. http://dx.doi.org/10.1007/978-0-387-77944-7_9.
Texto completo da fonteBaneman, Emily, e Meenakshi M. Rana. "Management of Acinetobacter Infections in the Immunosuppressed Host". In Emerging Transplant Infections, 1–19. Cham: Springer International Publishing, 2020. http://dx.doi.org/10.1007/978-3-030-01751-4_21-1.
Texto completo da fonteBaneman, Emily, e Meenakshi M. Rana. "Management of Acinetobacter Infections in the Immunosuppressed Host". In Emerging Transplant Infections, 371–89. Cham: Springer International Publishing, 2021. http://dx.doi.org/10.1007/978-3-030-25869-6_21.
Texto completo da fonteRajkumari, Jobina, e Busi Siddhardha. "Acinetobacter baumannii: Infections and Drug Resistance". In Model Organisms for Microbial Pathogenesis, Biofilm Formation and Antimicrobial Drug Discovery, 257–71. Singapore: Springer Singapore, 2020. http://dx.doi.org/10.1007/978-981-15-1695-5_14.
Texto completo da fonteRubinstein, E., e I. Levi. "Acinetobacter Infections in Intensive Care Units". In Yearbook of Intensive Care and Emergency Medicine, 542–51. Berlin, Heidelberg: Springer Berlin Heidelberg, 1996. http://dx.doi.org/10.1007/978-3-642-80053-5_44.
Texto completo da fonteJoly-Guillou, M. L., E. Bergogne-Bérézin e J. F. Vieu. "Epidemiology of Acinetobacter Strains Isolated from Nosocomial Infections in France". In The Biology of Acinetobacter, 63–68. Boston, MA: Springer US, 1991. http://dx.doi.org/10.1007/978-1-4899-3553-3_5.
Texto completo da fonteVergidis, Paschalis, e Matthew E. Falagas. "Control of Multi-Drug Resistant Acinetobacter Infections". In Antibiotic Policies, 117–25. New York, NY: Springer New York, 2011. http://dx.doi.org/10.1007/978-1-4419-1734-8_10.
Texto completo da fonteTrabalhos de conferências sobre o assunto "Infections à Acinetobacter – Chimiothérapie"
K. Alkhudhairy, Miaad, e Elhassan Benyagoub. "Frequency of Genes Mediated β-lactams Resistance in Acinetobacter Baumannii Isolates from Iraq". In X INTERNATIONAL CONGRESS OF PURE AND APPLIED TECHNOLOGICAL SCIENCES. Rimar Academy, 2023. http://dx.doi.org/10.47832/minarcongress10-2.
Texto completo da fonteAl-Ghanimi, Ali Abdul Kadhim, e Amaal Sahib Al-Zughaibi. "Molecular Identification of Acinetobacter baumannii and Staphylococcus aureus isolated from wound infections in Karbala governorate Iraq". In THE 9TH INTERNATIONAL CONFERENCE ON APPLIED SCIENCE AND TECHNOLOGY (ICAST 2021). AIP Publishing, 2022. http://dx.doi.org/10.1063/5.0113631.
Texto completo da fonteVrancianu, Corneliu Ovidiu, Roxana-Elena Cristian, Elena-Georgiana Dobre, Catalina Zenoaga-Barbarosie, Ecaterina-Teodora Chirea, Ioana Crunteanu e Mihai-Viorel Dionisie. "The Impact of Acinetobacter baumannii Infections in COVID-19 Patients Admitted in Hospital Intensive Care Units". In ECM 2023. Basel Switzerland: MDPI, 2023. http://dx.doi.org/10.3390/ecm2023-16479.
Texto completo da fonteGrosse-Onnebrink, Joerg, Heymut Omran, Johanna Rudloff e Claudius Werner. "Acinetobacter baumanii and Stenotrophomonas maltophilia are associated with lower airway infections in tracheostomised children and young adults". In ERS International Congress 2017 abstracts. European Respiratory Society, 2017. http://dx.doi.org/10.1183/1393003.congress-2017.pa4137.
Texto completo da fonteHodyna, Diana. "LONG-CHAIN TRIPHENYLPHOSPHONIUM IONIC LIQUIDS AS ANTIBACTERIALS IN POTENTIAL POLYMICROBIAL INFECTIONS CAUSED BY STAPHYLOCOCCUS AUREUS AND ACINETOBACTER BAUMANNII STRAINS". In THEORETICAL AND PRACTICAL ASPECTS OF MODERN SCIENTIFIC RESEARCH, Chair Ivan Semenyuta, Sergiy Rogalsky e Larysa Metelytsia. European Scientific Platform, 2023. http://dx.doi.org/10.36074/logos-28.04.2023.26.
Texto completo da fonteMisri, A. R. "To Study the Epidemiology of Multidrug Resistant Acinetobacter Infections Among Critically Ill Adult Patients Admitted in Medical Intensive Care Unit". In American Thoracic Society 2019 International Conference, May 17-22, 2019 - Dallas, TX. American Thoracic Society, 2019. http://dx.doi.org/10.1164/ajrccm-conference.2019.199.1_meetingabstracts.a6508.
Texto completo da fonteRelatórios de organizações sobre o assunto "Infections à Acinetobacter – Chimiothérapie"
Meddaugh, Paul, e Uzo Chukwuma. Acinetobacter Species Infections Among Navy and Marine Corps Beneficiaries: 2013 Annual Report. Fort Belvoir, VA: Defense Technical Information Center, novembro de 2014. http://dx.doi.org/10.21236/ada611595.
Texto completo da fonteMeddaugh, Paul, e Uzo Chukwuma. Acinetobacter Species Infections among Navy and Marine Corps Beneficiaries: 2014 Annual Report. Fort Belvoir, VA: Defense Technical Information Center, julho de 2015. http://dx.doi.org/10.21236/ada621496.
Texto completo da fonteMaraolo, Alberto Enrico, e David SY Ong. Colistin plus meropenem versus colistin alone for invasive infections caused by Carbapenem-Resistant Acinetobacter baumannii: a rapid systematic review of randomized controlled trials using Bayesian meta-analysis. INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols, janeiro de 2023. http://dx.doi.org/10.37766/inplasy2023.1.0055.
Texto completo da fonte